Gigantol is a bibenzyl compound derived from several medicinal orchids. Giganto shows promising therapeutic potential against cancer cells. Gigantol is a novel inhibitor of the Wnt/β-catenin pathway.
Physicochemical Properties
| Molecular Formula | C16H18O4 |
| Molecular Weight | 274.3117 |
| Exact Mass | 274.121 |
| CAS # | 67884-30-4 |
| PubChem CID | 3085362 |
| Appearance | White to off-white solid powder |
| Density | 1.204±0.06 g/cm3 |
| LogP | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 20 |
| Complexity | 284 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | SDXKZPQOVUDXIY-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C16H18O4/c1-19-14-8-12(7-13(17)10-14)4-3-11-5-6-16(20-2)15(18)9-11/h5-10,17-18H,3-4H2,1-2H3 |
| Chemical Name | 5-[2-(3-hydroxy-5-methoxyphenyl)ethyl]-2-methoxyphenol |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Gigantol isomer-1 lowers the amounts of phosphorylated LRP6 and cytosolic β-catenin in HEK293 cells. In breast cancer MDA-MB-231 and MDA-MB-468 cells, treatment with Gigantol isomer-1 lowered the levels of phosphorylated LRP6 [1]. Gigantol isomer-1 strongly suppresses the growth of HepG2 cells and promotes apoptosis. Gigantol isomer-1 at doses of 1, 40, and 150 μM significantly reduced cell viability by 11.7, 30.0, and 56.4% at 24 h, respectively, and by 21.1, 66.8, and 85.5% at 48 h, respectively. The IC50 value is 9.30 μM[2]. |
| ln Vivo | In comparison to mice given with a vehicle, rats treated with LDD and Gigantol isomer-1 (25–100 mg/kg, po) showed a significant increase in hot plate latency and a reduction in carrageenan-induced inflammation [2]. |
| References |
[1]. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells. BMC Complement Altern Med. 2018 Feb 14;18(1):59. [2]. Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-κB signaling pathway. Oncol Rep. 2017 Feb;37(2):865-870. [3]. Antinociceptive and anti-inflammatory effects of compounds isolated from Scaphyglottis livida and Maxillaria densa. J Ethnopharmacol. 2007 Nov 1;114(2):161-8. |
| Additional Infomation | Gigantol has been reported in Cymbidium giganteum, Dendrobium candidum, and other organisms with data available. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ≥ 100 mg/mL (~364.55 mM) Ethanol : ~50 mg/mL (~182.28 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.11 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.11 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (9.11 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.6455 mL | 18.2276 mL | 36.4551 mL | |
| 5 mM | 0.7291 mL | 3.6455 mL | 7.2910 mL | |
| 10 mM | 0.3646 mL | 1.8228 mL | 3.6455 mL |